IL133075A0 - Gelatine encapsulated solution dosage forms of sertraline - Google Patents

Gelatine encapsulated solution dosage forms of sertraline

Info

Publication number: IL133075A0
Authority: IL; Israel
Prior art keywords: sertraline; dosage forms; solution dosage; encapsulated solution; gelatine encapsulated
Prior art date: 1997-07-01

Application number

IL13307598A

Other languages

English (en)

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-01

Filing date

1998-06-16

Publication date

2001-03-19

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971076&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL133075(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-06-16 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2001-03-19 Publication of IL133075A0 publication Critical patent/IL133075A0/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Addiction (AREA)
Obesity (AREA)
Diabetes (AREA)
Hematology (AREA)
Pain & Pain Management (AREA)
Child & Adolescent Psychology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

IL13307598A 1997-07-01 1998-06-16 Gelatine encapsulated solution dosage forms of sertraline IL133075A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US5140197P	1997-07-01	1997-07-01
PCT/IB1998/000936 WO1999001113A1 (en)	1997-07-01	1998-06-16	Gelatine encapsulated solution dosage forms of sertraline

Publications (1)

Publication Number	Publication Date
IL133075A0 true IL133075A0 (en)	2001-03-19

Family

ID=21971076

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL13307598A IL133075A0 (en)	1997-07-01	1998-06-16	Gelatine encapsulated solution dosage forms of sertraline

Country Status (40)

Country	Link
EP (1)	EP0980241B1 (xx)
JP (1)	JP3585245B2 (xx)
KR (1)	KR100371730B1 (xx)
CN (1)	CN1261792A (xx)
AP (1)	AP945A (xx)
AR (1)	AR015916A1 (xx)
AT (1)	ATE256457T1 (xx)
AU (1)	AU724635B2 (xx)
BG (1)	BG103917A (xx)
BR (1)	BR9809712A (xx)
CA (1)	CA2290973C (xx)
CO (1)	CO4940405A1 (xx)
DE (1)	DE69820608T2 (xx)
DK (1)	DK0980241T3 (xx)
DZ (1)	DZ2544A1 (xx)
EA (1)	EA001905B1 (xx)
ES (1)	ES2210760T3 (xx)
GT (1)	GT199800090A (xx)
HR (1)	HRP980378B1 (xx)
HU (1)	HUP0002250A3 (xx)
ID (1)	ID24673A (xx)
IL (1)	IL133075A0 (xx)
IS (1)	IS5266A (xx)
MA (1)	MA24586A1 (xx)
MY (1)	MY119728A (xx)
NO (1)	NO996492L (xx)
NZ (1)	NZ501252A (xx)
OA (1)	OA11246A (xx)
PA (1)	PA8454001A1 (xx)
PE (1)	PE97299A1 (xx)
PL (1)	PL337807A1 (xx)
PT (1)	PT980241E (xx)
SK (1)	SK282914B6 (xx)
TN (1)	TNSN98123A1 (xx)
TR (1)	TR199903282T2 (xx)
TW (1)	TW382597B (xx)
UA (1)	UA68350C2 (xx)
UY (1)	UY25070A1 (xx)
WO (1)	WO1999001113A1 (xx)
ZA (1)	ZA985709B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6727283B2 (en)	1998-10-13	2004-04-27	Pfizer Inc.	Sertraline oral concentrate
AP2001002119A0 (en) *	1998-10-13	2001-03-22	Pfizer Prod Inc	Sertraline oral concentrate.
WO2001017521A1 (en)	1999-09-03	2001-03-15	Eli Lilly And Company	Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
MXPA03001771A (es)	2000-08-30	2003-06-04	Pfizer Prod Inc	Formulaciones de liberacion sostenida para secretagogos de hormona del crecimiento.
EP1375659A1 (en) *	2002-06-18	2004-01-02	Laboratorio di Diagnostica Moleculare	Soluble capsules containing stock mixtures for easy preparation of chemical or biological solutions
JP2006507309A (ja) *	2002-10-31	2006-03-02	アルザ・コーポレーシヨン	疎水性薬剤の上昇した生物学的利用性を提供する製剤
WO2016020936A2 (en) *	2014-07-21	2016-02-11	Patel Jayendrakumar Dasharathlal	A novel oral gastroretentive pharmaceutical dosage form
CN108014087A (zh) *	2017-12-27	2018-05-11	江苏联环药业股份有限公司	一种盐酸舍曲林胶囊的制备方法
GB2630572A (en)	2023-05-29	2024-12-04	Novumgen Ltd	An orally disintegrating tablet of sertraline and its process of preparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0782445B1 (en) *	1994-09-19	2002-03-13	Dupont Pharmaceuticals Company	Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence
ATE235237T1 (de) *	1995-07-17	2003-04-15	Pfizer	Sertralin zur behandlung von post-myocard-infarkt-patienten

1998
- 1998-06-16 EA EA199900963A patent/EA001905B1/ru not_active IP Right Cessation
- 1998-06-16 BR BR9809712-1A patent/BR9809712A/pt not_active Application Discontinuation
- 1998-06-16 SK SK1805-99A patent/SK282914B6/sk unknown
- 1998-06-16 HU HU0002250A patent/HUP0002250A3/hu unknown
- 1998-06-16 PT PT98923021T patent/PT980241E/pt unknown
- 1998-06-16 IL IL13307598A patent/IL133075A0/xx unknown
- 1998-06-16 ES ES98923021T patent/ES2210760T3/es not_active Expired - Lifetime
- 1998-06-16 AU AU75450/98A patent/AU724635B2/en not_active Ceased
- 1998-06-16 CN CN98806765A patent/CN1261792A/zh active Pending
- 1998-06-16 UA UA99116393A patent/UA68350C2/uk unknown
- 1998-06-16 DE DE69820608T patent/DE69820608T2/de not_active Expired - Fee Related
- 1998-06-16 EP EP98923021A patent/EP0980241B1/en not_active Expired - Lifetime
- 1998-06-16 PL PL98337807A patent/PL337807A1/xx unknown
- 1998-06-16 ID IDW991697A patent/ID24673A/id unknown
- 1998-06-16 CA CA002290973A patent/CA2290973C/en not_active Expired - Fee Related
- 1998-06-16 AT AT98923021T patent/ATE256457T1/de not_active IP Right Cessation
- 1998-06-16 JP JP50677699A patent/JP3585245B2/ja not_active Expired - Fee Related
- 1998-06-16 NZ NZ501252A patent/NZ501252A/en unknown
- 1998-06-16 TR TR1999/03282T patent/TR199903282T2/xx unknown
- 1998-06-16 WO PCT/IB1998/000936 patent/WO1999001113A1/en not_active Ceased
- 1998-06-16 DK DK98923021T patent/DK0980241T3/da active
- 1998-06-16 KR KR10-1999-7011596A patent/KR100371730B1/ko not_active Expired - Fee Related
- 1998-06-19 PA PA19988454001A patent/PA8454001A1/es unknown
- 1998-06-25 TW TW087110254A patent/TW382597B/zh not_active IP Right Cessation
- 1998-06-25 AP APAP/P/1998/001279A patent/AP945A/en active
- 1998-06-26 PE PE1998000575A patent/PE97299A1/es not_active Application Discontinuation
- 1998-06-29 GT GT199800090A patent/GT199800090A/es unknown
- 1998-06-29 MY MYPI98002949A patent/MY119728A/en unknown
- 1998-06-29 UY UY25070A patent/UY25070A1/es not_active IP Right Cessation
- 1998-06-29 AR ARP980103145A patent/AR015916A1/es not_active Application Discontinuation
- 1998-06-30 MA MA25145A patent/MA24586A1/fr unknown
- 1998-06-30 ZA ZA9805709A patent/ZA985709B/xx unknown
- 1998-06-30 TN TNTNSN98123A patent/TNSN98123A1/fr unknown
- 1998-06-30 DZ DZ980154A patent/DZ2544A1/xx active
- 1998-07-01 HR HR980378A patent/HRP980378B1/xx not_active IP Right Cessation
- 1998-07-01 CO CO98037136A patent/CO4940405A1/es unknown
1999
- 1999-11-23 BG BG103917A patent/BG103917A/bg unknown
- 1999-11-23 IS IS5266A patent/IS5266A/is unknown
- 1999-12-23 OA OA9900306A patent/OA11246A/en unknown
- 1999-12-27 NO NO996492A patent/NO996492L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
PL337807A1 (en)	2000-09-11
HUP0002250A3 (en)	2001-01-29
OA11246A (en)	2002-11-19
IS5266A (is)	1999-11-23
EP0980241A1 (en)	2000-02-23
AR015916A1 (es)	2001-05-30
HRP980378B1 (en)	2001-12-31
KR100371730B1 (ko)	2003-02-07
CA2290973A1 (en)	1999-01-14
UA68350C2 (en)	2004-08-16
CA2290973C (en)	2003-06-17
JP2000512316A (ja)	2000-09-19
TR199903282T2 (xx)	2000-08-21
AP945A (en)	2001-02-28
BG103917A (bg)	2000-07-31
TNSN98123A1 (fr)	2005-03-15
AU724635B2 (en)	2000-09-28
WO1999001113A1 (en)	1999-01-14
PT980241E (pt)	2004-03-31
AP9801279A0 (en)	1998-06-30
PA8454001A1 (es)	2000-05-24
SK282914B6 (sk)	2003-01-09
CO4940405A1 (es)	2000-07-24
PE97299A1 (es)	1999-10-13
HRP980378A2 (en)	1999-04-30
EP0980241B1 (en)	2003-12-17
SK180599A3 (en)	2001-01-18
KR20010013588A (ko)	2001-02-26
MY119728A (en)	2005-07-29
NO996492L (no)	2000-02-29
NZ501252A (en)	2004-11-26
CN1261792A (zh)	2000-08-02
AU7545098A (en)	1999-01-25
NO996492D0 (no)	1999-12-27
MA24586A1 (fr)	1998-12-31
ZA985709B (en)	2000-01-10
DE69820608D1 (de)	2004-01-29
DK0980241T3 (da)	2004-04-05
EA001905B1 (ru)	2001-10-22
DE69820608T2 (de)	2004-12-23
UY25070A1 (es)	2000-12-29
ES2210760T3 (es)	2004-07-01
ATE256457T1 (de)	2004-01-15
ID24673A (id)	2000-07-27
EA199900963A1 (ru)	2000-08-28
DZ2544A1 (fr)	2003-02-08
TW382597B (en)	2000-02-21
GT199800090A (es)	1999-12-21
JP3585245B2 (ja)	2004-11-04
BR9809712A (pt)	2000-07-11
HUP0002250A2 (hu)	2000-12-28

Publication	Publication Date	Title
AP9801281A0 (en)	1998-06-30	Sertraline salts and sustained-release dosage forms of sertraline
HUT71582A (en)	1995-12-28	Potentiation of drug response
HUP0105107A2 (en)	2002-06-29	Fast dispersing dosage forms free of gelatin
DE19681727T1 (de)	1999-05-12	Kapseln/Teilchen enthaltende Shampoo-Zusammensetzung
FI972555L (fi)	1997-06-16	Päällystettyjen tablettien valmistus
HUP0000759A3 (en)	2000-11-28	Dosage forms comprising separate portions of r- and s-enantiomers
HU9503835D0 (en)	1996-02-28	Soft gelatin pharmaceutical dosage form
SI0948541T1 (sl)	2006-06-30	PTHrP analogi
ZA975767B (en)	1998-12-28	Multiphase soft gelatin dosage form
AP9801278A0 (en)	1998-06-30	Delayed-release dosage forms of sertraline
IL133075A0 (en)	2001-03-19	Gelatine encapsulated solution dosage forms of sertraline
SI0980241T1 (en)	2004-04-30	Gelatine encapsulated solution dosage forms of sertraline
ZA948357B (en)	1996-04-24	Potentiation of drug response
ZA985707B (en)	2000-01-10	Sertraline salts and sustained-release dosage forms of sertraline.
GB9703750D0 (en)	1997-04-16	Treatment of haemorrhoids
HU9701917D0 (en)	1998-01-28	New compound of medicinal activity
AUPM590295A0 (en)	1995-11-02	Manufacture of pharmaceutical dosage forms
TW313845U (en)	1997-08-21	Improved structure of pacifier
BR9504107A (pt)	1997-09-09	Encapsulamento de peças anatômicas
TW314782U (en)	1997-09-01	Improved structure of mask
TW398283U (en)	2000-07-11	Improved structure of mask
UA1957S (uk)	1998-04-30	Етикетка медичного препарату "аспаркам"
UA1951S (uk)	1998-04-30	Етикетка медичного препарату "валідол"
UA2094S (uk)	1998-06-30	Етикетка медичного препарату "аспаркам"
ZA9811474B (en)	1999-06-15	Novel amines of pharmaceutical agents